Brokers say these 3 ASX 200 blue-chip shares are buys in December

Want some blue chips? Then check out these buy-rated shares

| More on:
Three people in a corporate office pour over a tablet, ready to invest.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're looking to add some ASX 200 blue-chip shares to your portfolio in December, then the three listed below could be worth considering.

These ASX 200 shares have all been named as buys by brokers recently. Here's what you need to know about them:

Endeavour Group Ltd (ASX: EDV)

Goldman Sachs thinks that Endeavour is an ASX 200 blue chip share to buy. It is the drinks giant behind the BWS and Dan Murphy's brands, as well as a huge network of hotels.

The broker believes that the company's shares are cheap based on its market leadership and positive outlook. It said:

Most attractive valuation amongst Staples peers: We continue to see defensiveness in the company's Retail business with relative market share of ~35% vs COL liquor of ~13%, 5.2mn active My Dan's members. EDV is currently trading at FY24e P/E of 18.4x with FY23-25e EPS CAGR of ~5%, which is the cheapest vs WOW, COL, WES.

Goldman has a conviction buy rating and a $6.40 price target on the company's shares.

Macquarie Group Ltd (ASX: MQG)

Another ASX 200 blue-chip share that could be a buy is Macquarie.

Morgans likes the investment bank for a number of reasons. This includes its exposure to long-term structural growth. The broker explains:

We continue to like MQG's exposure to long-term structural growth areas such as infrastructure and renewables. The company also stands to benefit from recent market volatility through its trading businesses, while it continues to gain market share in Australian mortgages.

Morgans has an add rating and a $182.80 price target on its shares.

ResMed Inc. (ASX: RMD)

A final ASX 200 blue-chip share that has been named as buy is ResMed. It is a sleep treatment-focused medical device company with a portfolio of leading hardware and digital solutions.

Goldman Sachs is also positive on the company and believes recent share price weakness has created a buying opportunity. It said:

We view the risk/reward to be favorable and are Buy-rated. We view valuation as attractive and see a favourable risk-reward skew post the recent de-rate, noting the shares are trading meaningfully below historical averages on both a P/E and EV/EBITDA basis.

Goldman has a buy rating and a $32 price target on the company's shares.

Motley Fool contributor James Mickleboro has positions in Endeavour Group and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Macquarie Group, and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Blue Chip Shares

These super-strong ASX 200 blue chip shares could deliver 20% returns

Analysts believe big returns could be on the cards for owners of these shares.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

ASX blue chip shares: The best of the best for February 2024

These top stocks are strong buys according to analysts.

Read more »

A woman looks shocked as she drinks a coffee while reading the paper.
Blue Chip Shares

Buy these top ASX 200 stocks for 18%+ returns

Analysts are tipping these shares to rise strongly from current levels.

Read more »

positive asx share price represented by lots of hands all making thumbs up gesture
Blue Chip Shares

Morgans says these ASX 50 shares are strong buys

These big-name stocks are buys this month according to the broker.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Blue Chip Shares

Why Goldman Sachs rates these ASX 200 shares as buys

Here's what the broker is saying about these top stocks.

Read more »

Man smiling at a laptop because of a rising share price.
Blue Chip Shares

3 top ASX 200 blue chip shares to buy in February

Analysts see big returns on offer from these buy-rated shares.

Read more »

Person holding blue chips.
Blue Chip Shares

3 ASX blue-chip stocks I think every Aussie should own

Every Aussie investor should consider adding these three ASX blue-chip stocks to their investment portfolio.

Read more »

world's biggest companies represented by one person holding cityscape and another holding earth in hands
Blue Chip Shares

2 world-class ASX 50 shares to buy for your portfolio

Analysts are saying good things about these

Read more »